New Dried Human Amniotic Membrane Is Useful as a Substitute for Dural Repair after Skull Base Surgery

Abstract

Objectives Cerebrospinal fluid (CSF) leakage is an undesirable complication of skull base surgery. We used dried human amniotic membrane (AM) as a patch graft for dural repair to determine its efficacy in preventing CSF leakage.

Design Frontoparietal craniotomy and removal of dura were performed in 20 Wistar rats. A dried AM was placed to cover the dural defect without suturing in 16 animals. In four animals, an expanded polytetrafluoroethylene was implanted. At 2 weeks and 1, 3, and 6 months, histological examination was performed. Dried AM was also used as a substitute in 10 patients who underwent skull base surgery, after approval by the Ethics Committee of the University of Toyama.

Results At 2 weeks after implantation, thick connective tissue completely enclosed the dried AM. At 1 month after implantation, the connective tissue became thin and the implanted AM shortened. At 3 and 6 months after implantation, histological examination revealed disappearance of the dried AM and formation of membranous tissue. In the clinical study, neither CSF leakage nor clinical adverse reactions directly related to the dried AM were observed.

Conclusion Dried human AM appears to be an ideal substitute for dura, since it is replaced by natural tissue.

Keywords

amniotic membrane - cerebrospinal fluid (CSF) leakage - dural repair - dural substitute - skull base surgery

• References

• 1 Parízek J, Mĕricka P, Husek Z , et al. Detailed evaluation of 2959 allogeneic and xenogeneic dense connective tissue grafts (fascia lata, pericardium, and dura mater) used in the course of 20 years for duraplasty in neurosurgery. Acta Neurochir (Wien) 1997; 139: 827-838
• 2 Masullo C, Pocchiari M, Macchi G, Alema G, Piazza G, Panzera MA. Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg 1989; 71: 954-955
• 3 Thadani V, Penar PL, Partington J , et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg 1988; 69: 766-769
• 4 Cohen AR, Aleksic S, Ransohoff J. Inflammatory reaction to synthetic dural substitute. Case report. J Neurosurg 1989; 70: 633-635
• 5 Simpson D, Robson A. Recurrent subarachnoid bleeding in association with dural substitute. Report of three cases. J Neurosurg 1984; 60: 408-409
• 6 Thompson DN, Taylor WF, Hayward RD. Silastic dural substitute: experience of its use in spinal and foramen magnum surgery. Br J Neurosurg 1994; 8: 157-167
• 7 Toda A, Okabe M, Yoshida T, Nikaido T. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci 2007; 105: 215-228
• 8 Kitagawa K, Yanagisawa S, Watanabe K , et al. A hyperdry amniotic membrane patch using a tissue adhesive for corneal perforations and bleb leaks. Am J Ophthalmol 2009; 148: 383-389
• 9 Macfarlane MR, Symon L. Lyophilised dura mater: experimental implantation and extended clinical neurosurgical use. J Neurol Neurosurg Psychiatry 1979; 42: 854-858
• 10 Narotam PK, van Dellen JR, Bhoola KD. A clinicopathological study of collagen sponge as a dural graft in neurosurgery. J Neurosurg 1995; 82: 406-412
• 11 Narotam PK, Qiao F, Nathoo N. Collagen matrix duraplasty for posterior fossa surgery: evaluation of surgical technique in 52 adult patients. Clinical article. J Neurosurg 2009; 111: 380-386
• 12 Stendel R, Danne M, Fiss I , et al. Efficacy and safety of a collagen matrix for cranial and spinal dural reconstruction using different fixation techniques. J Neurosurg 2008; 109: 215-221
• 13 Yamagata S, Goto K, Oda Y, Kikuchi H. Clinical experience with expanded polytetrafluoroethylene sheet used as an artificial dura mater. Neurol Med Chir (Tokyo) 1993; 33: 582-585
• 14 Yamada K, Miyamoto S, Nagata I , et al. Development of a dural substitute from synthetic bioabsorbable polymers. J Neurosurg 1997; 86: 1012-1017
• 15 Yamada K, Miyamoto S, Takayama M , et al. Clinical application of a new bioabsorbable artificial dura mater. J Neurosurg 2002; 96: 731-735
• 16 Narotam PK, Van Dellen JR, Bhoola K, Raidoo D. Experimental evaluation of collagen sponge as a dural graft. Br J Neurosurg 1993; 7: 635-641
• 17 McCall TD, Fults DW, Schmidt RH. Use of resorbable collagen dural substitutes in the presence of cranial and spinal infections-report of 3 cases. Surg Neurol 2008; 70: 92-96 , discussion 96–97
• 18 Pettorini BL, Tamburrini G, Massimi L, Paternoster G, Caldarelli M, Di Rocco C. The use of a reconstituted collagen foil dura mater substitute in paediatric neurosurgical procedures—experience in 47 patients. Br J Neurosurg 2010; 24: 51-54
• 19 Adinolfi M, Akle CA, McColl I , et al. Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells. Nature 1982; 295: 325-327
• 20 Akle CA, Adinolfi M, Welsh KI, Leibowitz S, McColl I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 1981; 2: 1003-1005
• 21 Hammer A, Hutter H, Blaschitz A , et al. Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G. Am J Reprod Immunol 1997; 37: 161-171
• 22 Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000; 19: 348-352
• 23 Kamiya K, Wang M, Uchida S , et al. Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea. Exp Eye Res 2005; 80: 671-679
• 24 Kubo M, Sonoda Y, Muramatsu R, Usui M. Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci 2001; 42: 1539-1546
• 25 Li H, Niederkorn JY, Neelam S , et al. Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 2005; 46: 900-907
• 26 Solomon A, Rosenblatt M, Monroy D, Ji Z, Pflugfelder SC, Tseng SCG. Suppression of interleukin 1 alpha and interleukin 1 beta in human limbal epitherial cells cultured on the amnotiv membrane stromal matrix. Br J Ophthalmol 2001; 85: 444-449
• 27 Talmi YP, Sigler L, Inge E, Finkelstein Y, Zohar Y. Antibacterial properties of human amniotic membranes. Placenta 1991; 12: 285-288
• 28 Tseng SCG, Li DQ, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol 1999; 179: 325-335
• 29 Sakuragawa N, Yoshikawa H, Sasaki M. Amniotic tissue transplantation: clinical and biochemical evaluations for some lysosomal storage diseases. Brain Dev 1992; 14: 7-11
• 30 Scaggiante B, Pineschi A, Sustersich M, Andolina M, Agosti E, Romeo D. Successful therapy of Niemann-Pick disease by implantation of human amniotic membrane. Transplantation 1987; 44: 59-61
• 31 Burman S, Tejwani S, Vemuganti GK, Gopinathan U, Sangwan VS. Ophthalmic applications of preserved human amniotic membrane: a review of current indications. Cell Tissue Bank 2004; 5: 161-175
• 32 Gibbs Jr CJ, Gajdusek DC, Latarjet R. Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie. Proc Natl Acad Sci U S A 1978; 75: 6268-6270
• 33 Becker SS, Jackler RK, Pitts LH. Cerebrospinal fluid leak after acoustic neuroma surgery: a comparison of the translabyrinthine, middle fossa, and retrosigmoid approaches. Otol Neurotol 2003; 24: 107-112
• 34 Ganly I, Patel SG, Singh B , et al. Complications of craniofacial resection for malignant tumors of the skull base: report of an international collaborative study. Head Neck 2005; 27: 445-451
• 35 Leonetti JP, Anderson D, Marzo S, Moynihan G. Prevention and management of cerebrospinal fluid fistula after transtemporal skull base surgery. Skull Base 2001; 11: 87-92
• 36 Mangham CA. Complications of translabyrinthine vs. suboccipital approach for acoustic tumor surgery. Otolaryngol Head Neck Surg 1988; 99: 396-400
• 37 Sen C, Snderman CH, Sekhar LN. Complications of skull base operation. In: Sekhar LN, Janacka IP, eds. Surgery of Cranial Base Tumors. New York: Rave Press; 1993: 831-839
• 38 Hakuba A, Nishimura S, Jang BJ. A combined retroauricular and preauricular transpetrosal-transtentorial approach to clivus meningiomas. Surg Neurol 1988; 30: 108-116
• 39 Jackson IT, Adham MN, Marsh WR. Use of the galeal frontalis myofascial flap in craniofacial surgery. Plast Reconstr Surg 1986; 77: 905-910
• 40 Kryzanski JT, Annino DJ, Gopal H, Heilman CB. Low complication rates of cranial and craniofacial approaches to midline anterior skull base lesions. Skull Base 2008; 18: 229-241